Patent · US Expired

Recombinant AAV vector-based transduction system and use of same

US6440742B1 · kind B1 · utility

0Cited by

0References

7Claims

0Family size

Assignee

Medi&Gene Inc. · DE

Inventors

Gerd Maass · Sindelsdorf, DE
Christoph Bogedain · Munich, DE
Michael Hallek · Cologne, DE
Clemens Wendtner · Munich, DE
Doris Michl · Munich, DE

Key dates

Filing date	Jan 30, 2001
Grant date	Aug 27, 2002
Priority date	—
Expiry date	Jan 30, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. The invention also relates to the use of the transduction system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.